Search Results for 'IDA Ireland'

Galway received a major jobs boost last evening when it was announced that insurance giant MetLife is to create 200 new positions at a Global Technology Campus in the city centre.

Galway received another jobs boost this week when it was confirmed that announced that MathWorks, the leading developer of mathematical computing software for engineers and scientists, is to establish a shared sales and services centre in Galway.

There was good news yesterday with the announcement that Coca-Cola plans to invest €26 million in its Ballina operation. The investment will see an additional 25 jobs created in the north Mayo facility over the next three years. The announcement was made by An Taoiseach Enda Kenny with Muhtar Kent, chairman and chief executive officer, The Coca-Cola Company.

An Australian computer technology firm has announced 100 jobs for Galway, with more expected to be confirmed should the company hit the ground running as expected.

Galway received a jobs boost yesterday when it was announced that ZELTIQ Aesthetics, Inc. a medical technology company focused on developing and commercialising products utilizing its proprietary controlled-cooling technology, is to establish a European manufacturing facility in the city, which is expected to create about 60 jobs over the next 18 months.

One hundred new jobs are to be created over the next five years in Ballinasloe by life sciences technologies company Surmodics, which plans to invest more than €7 million in its County Galway facility.

German company phenox GmbH is to establish a medical device manufacturing facility in Galway, creating up to 65 jobs over five years.The development is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.phenox Ireland Ltd. will manufacture interventional neurovascular medical devices for the treatment of aneurysms and stroke.

Medtronic plc, a global leader in medical technology, services and solutions, this week announced a new manufacturing facility in Galway that will manufacture the market-leading IN.PACT® Admiral® drug-coated balloon (DCB) for the treatment of peripheral artery disease (PAD). PAD is a build-up of plaque in arteries throughout the body leading to reduced blood flow to the limbs, organs, and the brain. Patients with PAD are at higher risk for stroke and heart attack.

Global medical technology company Medtronic’s has announced it will construct a new manufacturing facility in Galway, that will manufacture the IN.PACT Admiral drug-coated balloon for the treatment of peripheral artery disease.